Pharmacies, Drug Wholesaler File Lawsuit Against Abbott Over Norvir Price
October 30, 2007
Four pharmacy chains and one pharmaceutical wholesaler on Monday filed a lawsuit against Abbott Laboratories over the price of its antiretroviral drug Norvir, the Wall Street Journal reports. In the suit, the companies -- Safeway, Walgreen, Kroger, Supervalu's New Albertson's and American Sales -- allege that Abbott "unlawfully extended its monopoly position as the sole provider of Norvir" by increasing its price in 2003 (Carreyrou, Wall Street Journal, 10/30).
Abbott has said that it did not increase the price of Norvir to promote Kaletra and that the increase did not affect other drug companies. According to Abbott, the price increase was intended to better show Norvir's medical value.
Illinois Attorney General Lisa Madigan (D) has been investigating Norvir's price increase for three years and has said that it might violate the state's consumer fraud law. In addition, two HIV-positive people and the Service Employees International Union's Health and Welfare Fund have filed a lawsuit in U.S. district court in Oakland, Calif. (Kaiser Daily HIV/AIDS Report, 1/3). That trial is scheduled to start in June, according to the Journal. Abbott spokesperson Scott Stoffel recently said the lawsuit filed on Monday is without merit (Wall Street Journal, 10/30).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.